Assistant Professor, Medicine, Vanderbilt University School of Medicine
Oncology
Dr. Brent N. Rexer, MD
|
|
Give Review
Brent Rexer is an expert in the field of Oncology. He attended Vanderbilt University School of Medicine. Brent N. Rexer is a published MD as well. He has 17 publications published. The latest was: Evaluating HER2 amplification status and acquired drug resistance in breast cancer cells using Raman spectroscopy. He accepts all Medicare patients.
Publications
- Evaluating HER2 amplification status and acquired drug resistance in breast cancer cells using Raman spectroscopy.
- Human Breast Cancer Cells Harboring a Gatekeeper T798M Mutation in HER2 Overexpress EGFR Ligands and Are Sensitive to Dual Inhibition of EGFR and HER2.
- Conditional Loss of ErbB3 Delays Mammary Gland Hyperplasia Induced by Mutant PIK3CA without Affecting Mammary Tumor Latency, Gene Expression, or Signaling.
- Optimal Targeting of HER2-PI3K Signaling in Breast Cancer: Mechanistic Insights and Clinical Implications.
- Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer.
- Using Tandem Mass Spectrometry in Targeted Mode to Identify Activators of Class IA PI3K in Cancer.
- Inhibition of PI3K and MEK: it is all about combinations and biomarkers.
- Overcoming resistance to tyrosine kinase inhibitors: lessons learned from cancer cells treated with EGFR antagonists.
- A novel short-chain alcohol dehydrogenase from rats with retinol dehydrogenase activity, cyclically expressed in uterine epithelium.
- Retinoic acid does not affect alveolar septation in adult FVB mice with elastase-induced emphysema.
- H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3.
- Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition.
- Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells.
- Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells.
- CRBP suppresses breast cancer cell survival and anchorage-independent growth.
- Optical imaging of metabolism in HER2 overexpressing breast cancer cells.
Schools
Vanderbilt University School Of Medicine
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Network S
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Coventry Health Care of Tennessee PPO
- Choice Care PPO
- Medicare MCR
- PHCS Network PPO
- POMCO Group
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Education
-
Vanderbilt University -
Vanderbilt University School of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1306896519 |
| Last Name Of The Provider | REXER |
| First Name Of The Provider | BRENT |
| View All |
Similar Doctors
|
Dr. Adetola A. Kassim, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Jack W. Erter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nancy W. Peacock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd M. Bauer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vicki L. Keedy, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Howard A. Burris III, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jeffrey R. Infante, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Carl R. Willis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mace L. Rothenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sally J. York, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanford B. Krantz, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|